Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia.
Blood
; 135(8): 542-546, 2020 02 20.
Article
in En
| MEDLINE
| ID: mdl-31880804
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Agents, Immunological
/
Gemtuzumab
/
Mutation
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Blood
Year:
2020
Type:
Article
Affiliation country:
France